Mesomark assay
From Wikipedia, the free encyclopedia
 |
This article is orphaned as few or no other articles link to it. Please help introduce links in articles on related topics. (December 2007) |
The Mesomark Assay is an in vitro test to monitor and possibly diagnose Mesothelioma.[1]
Developed by Fujirebio Diagnostics and approved in late January 2007[1] by the FDA it works by measuring levels of soluble mesothelin-related proteins (SMRPs) released by diseased mesothelioma cells. The SMRP levels correlate directly with tumor volume thus permitting less invasive monitoring and improved assessment of treatment response.
In the future, the test may be used as an early detection measure as evidenced by recently sponsored tests by the Early Detection Research Network of the National Cancer Institute[2].
[edit] References
- ^ Beyer, HL; Geschwindt RD, Glover CL et al. (April 2007). "MESOMARK: a potential test for malignant pleural mesothelioma". Clinical Chemistry 53 (4): 666–672. doi:. PMID 17289801.
[edit] External links
 |
This oncology article is a stub. You can help Wikipedia by expanding it. |
 |
This medical sign article is a stub. You can help Wikipedia by expanding it. |
